Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Clinical properties and non-clinical testing of mineralocorticoid receptor antagonists in in vitro cell models
ID
Varda, Luka
(
Author
),
ID
Ekart, Robert
(
Author
),
ID
Lainščak, Mitja
(
Author
),
ID
Maver, Uroš
(
Author
),
ID
Bevc, Sebastjan
(
Author
)
PDF - Presentation file,
Download
(4,55 MB)
MD5: 83961C021D1C6245FC8003987426235D
URL - Source URL, Visit
https://www.mdpi.com/1422-0067/25/16/9088
Image galllery
Abstract
Mineralocorticoid receptor antagonists (MRAs) are one of the renin–angiotensin–aldosterone system inhibitors widely used in clinical practice. While spironolactone and eplerenone have a long-standing profile in clinical medicine, finerenone is a novel agent within the MRA class. It has a higher specificity for mineralocorticoid receptors, eliciting less pronounced adverse effects. Although approved for clinical use in patients with chronic kidney disease and heart failure, intensive non-clinical research aims to further elucidate its mechanism of action, including dose-related selectivity. Within the field, animal models remain the gold standard for non-clinical testing of drug pharmacological and toxicological properties. Their role, however, has been challenged by recent advances in in vitro models, mainly through sophisticated analytical tools and developments in data analysis. Currently, in vitro models are gaining momentum as possible platforms for advanced pharmacological and pathophysiological studies. This article focuses on past, current, and possibly future in vitro cell models research with clinically relevant MRAs.
Language:
English
Keywords:
finerenone
,
mineralocorticoids
,
spironolactone
,
eplerenone
,
in vitro techniques
,
mineralocorticoid receptor antagonists
Work type:
Article
Typology:
1.02 - Review Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
21 str.
Numbering:
Vol. 25, iss. 16, art. 9088
PID:
20.500.12556/RUL-169397
UDC:
616.6
ISSN on article:
1422-0067
DOI:
10.3390/ijms25169088
COBISS.SI-ID:
205135619
Publication date in RUL:
27.05.2025
Views:
276
Downloads:
86
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
International journal of molecular sciences
Shortened title:
Int. j. mol. sci.
Publisher:
MDPI
ISSN:
1422-0067
COBISS.SI-ID:
2779162
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0036
Name:
Bio-psiho-socialni model kvalitete življenja
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
N1-0305
Name:
Nova platforma za razvoj ADME modelov v farmakologiji
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J3-4524
Name:
Razvoj naprednih večdimenzionalnih in vitro modelov ledvic
Funder:
University Medical Center Maribor
Project number:
IRP 2018/01-07
Funder:
University Medical Center Maribor
Project number:
IRP 2021/02-17
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back